Policy & Regulation
14 December 2018 - - US-based synaptopathies drug developer Rodin Therapeutics has initiated a Phase 1 clinical trial of the company's lead candidate, RDN-929, a potent and selective HDAC-CoREST ...
14 December 2018 - - US-based life sciences and technology company InterVenn BioSciences has received an institutional investment of USD 9.4m led by seasoned biotech investor Genoa Ventures, with part...
14 December 2018 - Autoimmune diseases company Eli Lilly and Company (NYSE:LLY) said on the US Food and Drug Administration's (FDA) fast track designation to facilitate the development and expedi...
14 December 2018 - ESSA Pharma Inc (TSX-V: EPI)(NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, reported yesterday its financial res...
14 December 2018 - Belgium-based Janssen Pharmaceutical's Tremfya (guselkumab) was found to be superior to Cosentyx (secukinumab) for the primary endpoint evaluated at week 48 of a phase three tr...
13 December 2018 - - US-based biopharmaceutical company Aveo Oncology (NASDAQ: AVEO) has entered into a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca'...